Trial intelligence / Profile preview

Paclitaxel plus GDC-0941 vs paclitaxel plus placebo in metastatic breast cancer

2012-003262-41Phase 2Completed

Sponsor
Genentech
Start
Jan 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pictilisib in breast cancer, sponsored by Genentech. Started Jan 2013; status: completed.

02

Drugs

pictilisib
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2012-003262-41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-003262-41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call